Toronto Stocks Slide, George Weston Falls on Lower 3Q Profit
By Adriano Marchese
Stocks in Toronto were slightly lower.
In Tuesday's session, most sectors were trending down, led by tech, producer manufacturing and utilities. Only materials and health tech were posting any gains.
Canada's S&P/TSX Composite Index was 0.42% lower at 20161.45 and the blue-chip S&P/TSX 60 fell by 0.42% to 1215.94.
Canada's consumer price index rose 3.1% in October from a year earlier, the lowest rate since June, according to Statistics Canada, following inflation of 3.8% in September.
Shares of George Weston fell by 3.7% to 158.50 Canadian dollars ($115.49) after the company reported a decline in profit in its third quarter because of an unfavorable fair-value adjustment on its properties, while revenue rose in the period.
Other market movers:
Karora Resources shares were 5.3% higher at C$4.43 after reporting increases in the size of the resources at its Australian gold mines.
TransAlta said it will invest about C$3.5 billion to add more capacity to its fleet by way of acquisition, construction or development, aiming for higher growth by the end of 2028. Shares were down 7.2% to C$10.73.
Write to Adriano Marchese at adriano.marchese@wsj.com
(END) Dow Jones Newswires
November 21, 2023 12:29 ET (17:29 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
How to Measure a Stock’s Uncertainty
-
How to Determine Whether a Stock Is Cheap, Expensive, or Fairly Valued
-
Why a Company’s Management and Capital Allocation Matter
-
How to Determine What a Stock Is Worth
-
How to Measure a Company’s Competitive Advantage
-
How to Think Like a Stock Analyst
-
How GLP-1 Drugs Like Ozempic Are Boosting Biopharma Stocks